Brazil - Healthcare, Regulatory and Reimbursement Landscape

Brazil - Healthcare, Regulatory and Reimbursement Landscape

  • September 2021 •
  • 176 pages •
  • Report ID: 6153508 •
  • Format: PDF
Brazil - Healthcare, Regulatory and Reimbursement Landscape

Summary
The analyst has released its latest report, “Brazil - Healthcare, Regulatory and Reimbursement Landscape”.The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Brazil.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

Brazil, which has guaranteed healthcare access through the Unified Health System (Sistema Único de Saúde, SUS), and a high elderly population, is among the top 10 pharmaceutical markets.Brazil faces increasing demand for all kinds of medicines, especially those used to treat chronic diseases like cancer, heart disease, and respiratory issues.

The upsurge in non-communicable diseases makes Brazil one of the world’s biggest consumers of medications. In terms of Brazilian Reals, the country’s pharmaceutical market increased from R$57.9B in 2013 to R$126.2B in 2020. It is estimated to increase at a Compound Annual Growth Rate (CAGR) of 13% to R$229.8B in 2025. In the terms of US Dollars, the Brazilian pharmaceutical market decreased from $26.9B in 2013 to $24.6B in 2020, which is estimated to decrease at a negative CAGR of 4% to $20.2B in 2025. The difference is due to currency fluctuations. The medical devices market in Brazil was valued at $16.02B in 2015, which increased to $19.81B in 2020 at a CAGR of 4.3%. The market is expected to grow at a CAGR of 1.9% from $19.73B in 2021 to $21.27B in 2025.

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: GSK, Pfizer, Novartis, Sanofi, and EMS
- Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Hologic, Zimmer Biomet, and Medtronic
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in Brazilian healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Brazil healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Brazil healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.